These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 19007681)

  • 1. Trials with thyroid hormone in preterm infants: clinical and neurodevelopmental effects.
    van Wassenaer AG; Kok JH
    Semin Perinatol; 2008 Dec; 32(6):423-30. PubMed ID: 19007681
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ten-year follow-up of children born at <30 weeks' gestational age supplemented with thyroxine in the neonatal period in a randomized, controlled trial.
    van Wassenaer AG; Westera J; Houtzager BA; Kok JH
    Pediatrics; 2005 Nov; 116(5):e613-8. PubMed ID: 16234230
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thyroid function in preterm newborns; is T4 treatment required in infants < 27 weeks' gestational age?
    Van Wassenaer AG; Kok JH; Briët JM; van Baar AL; de Vijlder JJ
    Exp Clin Endocrinol Diabetes; 1997; 105 Suppl 4():12-8. PubMed ID: 9439908
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increasing supplemental thyroid hormone use among premature infants born at 23 to 32 weeks' gestation.
    Linn M; Yoder BA; Clark RH
    Am J Perinatol; 2010 Oct; 27(9):731-5. PubMed ID: 20408110
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Perinatal factors affecting thyroid hormone status in extreme preterm infants.
    Williams FL; Hume R
    Semin Perinatol; 2008 Dec; 32(6):398-402. PubMed ID: 19007676
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hypothyroxinaemia and thyroid function after preterm birth.
    van Wassenaer AG; Kok JH
    Semin Neonatol; 2004 Feb; 9(1):3-11. PubMed ID: 15013471
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neurodevelopmental follow-up of very preterm infants after proactive treatment at a gestational age of > or = 23 weeks.
    Steinmacher J; Pohlandt F; Bode H; Sander S; Kron M; Franz AR
    J Pediatr; 2008 Jun; 152(6):771-6, 776.e1-2. PubMed ID: 18492513
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hypothyroxinemia of prematurity: rite of passage or therapeutic necessity?
    Beeram MR; Wilson DP
    Tex Med; 2000 Nov; 96(11):60-3. PubMed ID: 11125989
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of higher versus lower dexamethasone doses on pulmonary and neurodevelopmental sequelae in preterm infants at risk for chronic lung disease: a meta-analysis.
    Onland W; De Jaegere AP; Offringa M; van Kaam AH
    Pediatrics; 2008 Jul; 122(1):92-101. PubMed ID: 18595991
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Does the loss of placental hormones contribute to neurodevelopmental disabilities in preterm infants?
    Reuss ML; Paneth N; Susser M
    Dev Med Child Neurol; 1994 Aug; 36(8):743-7. PubMed ID: 7519571
    [No Abstract]   [Full Text] [Related]  

  • 11. Thyroid system immaturities in very low birth weight premature infants.
    Fisher DA
    Semin Perinatol; 2008 Dec; 32(6):387-97. PubMed ID: 19007675
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Is it possible to protect the preterm infant brain and to decrease later neurodevelopmental disabilities?].
    Marret S; Foix-L'hélias L; Ancel PY; Kaminski M; Larroque B; Marcou-Labarre A; Laudenbach V
    Arch Pediatr; 2008 Jun; 15 Suppl 1():S31-41. PubMed ID: 18822257
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transient hypothyroxinaemia in preterm infants.
    Williams FL; Visser TJ; Hume R
    Early Hum Dev; 2006 Dec; 82(12):797-802. PubMed ID: 17079099
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of patent ductus arteriosus and severe hypothyroidism in term newborns: coincidence or causal?
    Allegaert K; Vanhole C; Van Helvoirt M; Vanhaesebrouck S; Gewillig M; Debeer A; Devlieger H; de Zegher F
    J Matern Fetal Neonatal Med; 2004 Dec; 16(6):339-41. PubMed ID: 15621552
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of inhaled nitric oxide in the preterm infant.
    Steinhorn RH; Porta NF
    Curr Opin Pediatr; 2007 Apr; 19(2):137-41. PubMed ID: 17496754
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adverse neurodevelopmental outcome in preterm infants: risk factor profiles for different gestational ages.
    Kiechl-Kohlendorfer U; Ralser E; Pupp Peglow U; Reiter G; Trawöger R
    Acta Paediatr; 2009 May; 98(5):792-6. PubMed ID: 19191762
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antenatal magnesium sulphate neuroprotection in the preterm infant.
    Marret S; Doyle LW; Crowther CA; Middleton P
    Semin Fetal Neonatal Med; 2007 Aug; 12(4):311-7. PubMed ID: 17513184
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Short-term outcome of PDA ligation in the preterm infants at King Chulalongkorn Memorial Hospital, Thailand.
    Benjacholmas V; Namchaisiri J; Lertsarpcharoen P; Punnahitananda S; Thaithumyanon P
    J Med Assoc Thai; 2009 Jul; 92(7):909-13. PubMed ID: 19626809
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Infant sex, obstetric risk factors, and 2-year neurodevelopmental outcome among preterm infants.
    Spinillo A; Montanari L; Gardella B; Roccio M; Stronati M; Fazzi E
    Dev Med Child Neurol; 2009 Jul; 51(7):518-25. PubMed ID: 19416336
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thyroid function and dysfunction in premature infants.
    Fisher DA
    Pediatr Endocrinol Rev; 2007 Jun; 4(4):317-28. PubMed ID: 17643079
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.